Nutritional supplement to treat macular degeneration

  • US 20020182266A1
  • Filed: 03/23/2001
  • Published: 12/05/2002
  • Est. Priority Date: 03/23/2001
  • Status: Active Grant
First Claim
Patent Images

1. A composition comprising:

  • approximately 7 to 10 times the RDA of vitamin C;

    approximately 13 to 18 times the RDA of vitamin E;

    approximately 6 to 10 times the RDA of vitamin A in the form of beta-carotene;

    approximately 4 to 7 times the RDA of zinc; and

    approximately the RDA of copper.

View all claims
    ×
    ×

    Thank you for your feedback

    ×
    ×